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ABSTRACT 
 
This article reviews and critiques the DSM-IV-TR diagnostic criteria for Female Sexual 
Arousal Disorder (FSAD). An overview of how the diagnostic criteria for FSAD have 
evolved over previous editions of the DSM is presented and research on prevalence and 
etiology of FSAD is briefly reviewed. Problems with the essential feature of the DSM-IV-TR 
diagnosis--“an inability to attain, or to maintain…an adequate lubrication-swelling response 
of sexual excitement”--are identified. The significant overlap between “arousal” and “desire” 
disorders is highlighted. Finally, specific recommendations for revision of the criteria for 
DSM-V are made, including use of a polythetic approach to the diagnosis and the addition of 
duration and severity criteria. 
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INTRODUCTION 
“…diagnostic categories are simply concepts, justified only by whether they provide a useful 
framework for organizing and explaining the complexity of clinical experience in order to 
derive inferences about outcome and to guide decisions about treatment.” (Kendell & 
Jablensky, 2003, p. 5) 
 
The third edition of the Diagnostic and Statistical Manual of Mental Disorders 
(DSM) (American Psychiatric Association, 1980) was the first to include the category of 
Psychosexual Disorders, defined as “inhibitions in sexual desire or the psychophysiological 
changes that characterize the sexual response cycle” (p. 261). Utilizing the human sexual 
response cycle (HRSC) model developed by Masters and Johnson (1966) as the framework, 
“inhibition” could occur at any one or more of the following “phases”: appetitive, excitement, 
orgasm, and resolution. The most recent edition of DSM (DSM-IV-TR) (American 
Psychiatric Association, 2000) preserved this basic structure, classifying sexual dysfunctions 
into the following categories: Sexual Desire Disorders, Sexual Arousal Disorders, Orgasmic 
Disorders, Sexual Pain Disorders, Sexual Dysfunction due to a General Medical Condition, 
Substance-Induced Sexual Dysfunction, and Sexual Dysfunction Not Otherwise Specified. 
The purpose of this paper is to review and critique the DSM diagnostic criteria for 
Female Sexual Arousal Disorder (FSAD). An overview of how the diagnostic criteria for 
FSAD have evolved over the last three editions of the DSM will first be presented. Following 
this, research on the prevalence and etiology of FSAD will be reviewed, and the relationship 
between arousal problems and distress discussed. Previous critiques of DSM and revised 
definitions that have been put forward will be reviewed. The specific diagnostic criteria for 
FSAD will be critically examined and key issues that should be considered for DSM-V 
identified. Finally, recommendations will be made for revision of the criteria. 
REVIEW OF THE DIAGNOSTIC CRITERIA FOR FSAD (DSM-III, DSM-III-R, AND 
DSM-IV) 
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The DSM-III diagnostic criteria for “Inhibited Sexual Excitement” are presented in 
Table 1. Note that, unlike subsequent editions of DSM, the same diagnostic label was used 
for men and women. This reflected the assumption at the time that male and female sexual 
response were similar and that vaginal lubrication was the counterpart to male penile 
erection. Although the DSM-III text described the excitement phase as consisting of “a 
subjective sense of sexual pleasure and accompanying physiological changes” (p. 276), the 
diagnostic criteria themselves only required impairment in genital arousal (penile erection in 
the male and lubrication/swelling in the female). 
In DSM-III-R (American Psychiatric Association, 1987), the Sexual Arousal 
Disorders were subdivided into Male Erectile Disorder (302.72) and Female Sexual Arousal 
Disorder (302.72). There was one important change in the diagnostic criteria for both sexes: 
Criterion A now required either impaired genital response (lubrication/swelling in the case of 
women, erection for men) or “persistent or recurrent lack of a subjective sense of sexual 
excitement and pleasure...during sexual activity” (see Table 2). The DSM-III-R text noted 
that, “In most instances there will be a disturbance in both the subjective sense of pleasure or 
desire and objective performance” (p. 261). 
In DSM-IV and DSM-IV-TR (American Psychiatric Association, 1994, 2000), lack of 
subjective excitement and pleasure was dropped from Criterion A for both male and female 
arousal disorders. Thus, in women, the diagnosis of FSAD could be made solely on the basis 
of impairment of “an adequate lubrication-swelling response” (see Table 3). In contrast with 
earlier DSM-III and III-R texts (which referred to subjective pleasure and non-genital 
physiologic changes such as breast tumescence), the emphasis in the DSM-IV text also 
shifted to genital changes associated with sexual arousal. For example, the “major” changes 
associated with sexual excitement were described as: “vasocongestion in the pelvis, vaginal 
lubrication and expansion, and swelling of the external genitalia” (p. 494). The one mention 
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of subjective response in the text on FSAD reflects the lesser importance ascribed to 
subjective pleasure and excitement compared to genital arousal: “The individual with Female 
Sexual Arousal Disorder may have little or no subjective sense of sexual arousal” (p. 501) 
(my emphasis). The Work Group recommended that rather than retain the concept of 
subjective excitement and pleasure in the diagnostic criteria, diminished subjective sexual 
feelings are listed as an example of a Sexual Dysfunction Not Otherwise Specified (SDNOS) 
(302.70). 
It is interesting to consider the rationale for this increased focus on genital indicators 
of arousal and the removal of subjective feelings of sexual excitement and pleasure from the 
DSM-IV criteria. The DSM-III-R criteria were considered problematic for two reasons: (1) 
the vagueness of the criteria and the extent to which clinician judgement was required to 
make a diagnosis and (2) the combination of both subjective and physiological symptom 
criteria, particularly when studies had found poor concordance between subjective measures 
of arousal and genital measures, such as vaginal pulse amplitude (VPA), in women 
(Segraves, 1996a). Examination of the DSM-IV Sourcebook (Segraves, 1996a) reveals that, 
in the lead-up to DSM-IV, three options were considered: (1) deletion of the FSAD diagnosis 
(on the grounds that there was little evidence either of the clinical utility of the diagnosis or 
that FSAD existed as a “discrete syndrome”); (2) retention of the FSAD diagnosis and the 
DSM-III-R criteria; (3) modification of the criteria so that Criterion A include only impaired 
vaginal lubrication and not subjective response. Interestingly, although a literature review 
carried out supported deletion of the FSAD category (Option 1), the Work Group 
recommended Option 3 on the grounds that this would maintain “compatibility between the 
sexes and between the DSM-IV and ICD-10” (Segraves, 1996a, p. 1006). The Work Group 
recommendations pertaining to Male Erectile Disorder (ED) also called for the diagnostic 
criteria to be modified so that only erectile failure (and not reduced subjective excitement) 
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was required. The justification here was that in research studies the diagnosis of ED was 
based on “objective criteria alone” and that, clinically, “there is no evidence that men exist 
who have decreased sexual arousal in the absence of desire or orgasm dysfunction” 
(Segraves, 1996b, p. 1110).  
The International Statistical Classification of Diseases and Related Health Problems 
(ICD-10) (World Health Organization, 1992) does have a diagnostic category of “Failure of 
Genital Response” (F52.2), but there is also a separate category labelled “Sexual Aversion 
and Lack of Sexual Enjoyment” (F52.1). Thus, although the Work Group sought “full 
compatibility with ICD-10” (Segraves, 1996a), this was not, in fact, what was achieved by 
removing subjective excitement and pleasure from the FSAD criteria.  
Another major change in DSM-IV was the inclusion of Criterion B (i.e., the 
requirement that the problem causes “marked distress or interpersonal difficulty”); this 
criterion was added to the criteria sets for all the sexual dysfunctions in DSM-IV. The 
relationship between distress and symptoms of FSAD will be discussed below. 
Criterion C of DSM-IV criteria for FSAD restricted the diagnosis to those cases 
where “the sexual dysfunction is not better accounted for by another Axis I disorder (except 
another Sexual Dysfunction) and is not due exclusively to the direct physiological effects of a 
substance…or a general medical condition.” 
In DSM-III-R (American Psychiatric Association, 1987), subtyping (lifelong or 
acquired; generalized or situational; psychogenic only or psychogenic and biogenic) had been 
added. Although these subtypes were retained in DSM-IV-TR, “psychogenic only” was 
renamed “due to psychological factors” and “psychogenic and biogenic” changed to “due to 
combined factors.”  
Although more precise duration and severity criteria were considered by the DSM-IV 
Work Group for some of the sexual dysfunctions (e.g., ED) (Segraves, 1996b), the lack of 
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empirical data on the relationship between severity and duration criteria and treatment 
outcome ruled this out. For FSAD, however, the DSM-IV text included this statement: 
“Occasional problems with sexual arousal that are not persistent or recurrent…are not 
considered to be Female Sexual Arousal Disorder” (p. 501). Similarly, a diagnosis of FSAD 
should not be given if the problems in arousal are “due to sexual stimulation that is not 
adequate in focus, intensity, and duration” (p. 501). 
BACKGROUND 
Concept of Sexual Arousal and Underlying Mechanisms 
The term sexual arousal has been used in a variety of ways (Bancroft, 2005; Singer, 
1984). Although some authors discuss sexual arousal as if it is synonymous with genital 
arousal, the concept is much broader than this. It has been defined as “a state motivated 
towards the experience of sexual pleasure and possibly orgasm, and involving (i) information 
processing of relevant stimuli, (ii) arousal in a general sense, (iii) incentive motivation and 
(iv) genital response” (Bancroft, 2005, p. 411). A distinction can be made between the “state” 
of sexual arousal and “sexual arousability,” with the latter referring to an individual‟s 
disposition to respond to sexual cues with sexual arousal, which varies across and within 
individuals (Bancroft, 2005; Laan & Both, 2008). 
The Masters and Johnson HSRC model and Kaplan‟s (1974) model of human sexual 
response characterized sexual response as a universal, essentially linear progression from 
sexual desire, through the stages of arousal, orgasm, and resolution. These stages were 
conceptualized as discrete phases, with the possibility of specific impairments at any one or 
more of the phases; as discussed above, the DSM-IV classification system is based on this 
model. The HRSC model has received much criticism, particularly regarding its applicability 
to women (e.g., Boyle, 1994; Hartmann, Heiser, Ruffer-Hesse, & Kloth, 2002; Levin, 2008; 
Tiefer, 1991).  
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Focusing on incentive motivation, the model put forward by Laan and Janssen (2007) 
defines sexual motivation as “the result of the activation of a sensitive sexual response system 
by sexually competent stimuli that are present in the environment” (p. 329; see also Laan & 
Everaerd, 1995). Both sexual arousal and sexual desire are viewed as responses to a sexually 
relevant stimulus. Sexual “desire” may reflect early arousal processes (Everaerd, Laan, Both, 
& van der Velde, 2000) and it is argued that there is no such thing as spontaneous sexual 
desire (Laan & Both, 2008). Sexual thoughts or sexual activity act as stimuli, which then 
trigger the desire-arousal process. Individuals have variable tendencies to respond to sexual 
stimuli (often referred to as “arousability”) (Laan & Both, 2008). While the drive model 
assumes that we have sex because we feel desire (Laan & Janssen, 2007), the incentive 
motivation model instead suggests that we feel sexual desire because we have sex or think 
about sex (Laan & Both, 2008). In other words, sexual thoughts or sexual activity act as 
stimuli, which then trigger the desire/arousal process. Everaerd et al. (2000) suggested that, in 
comparison with men, genital changes might influence subjective experience of sexual 
arousal in women to a lesser extent than external, contextual cues. There is now a 
considerable body of evidence that supports this model (Both, Everaerd, & Laan, 2003; Laan 
& Everaerd, 1995; Laan & Janssen, 2007; for review, see Toates, 2009). 
Another model of female sexual response, similar in some ways to the incentive 
motivation model, was put forward by Basson (2000), who suggested that women most 
frequently engage in sexual activity not because of any intrinsic sexual desire, but from a 
state of “sexual neutrality” and primarily motivated by non-sexual reasons, such as desire for 
emotional closeness with a partner. According to this model, a combination of incentives for 
sexual activity, appropriate sexual stimuli for the woman, and a context conducive to 
facilitating her arousal (e.g., privacy, lack of distractions, etc.) would encourage the 
experience of sexual arousal. If this sexual arousal was positive for the woman, this then 
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triggered a “desire” for her to continue the sexual encounter, now for both non-sexual and 
sexual reasons. This emergent desire (which followed arousal) was termed “responsive sexual 
desire.” Basson (2000) also argued that sexual arousal in women is “more a mental 
excitement, very much about the appreciation of the sexual stimulus and less about the 
awareness of genital changes” (p. 63). 
 A study by Sand and Fisher (2007) challenged the idea that there is one underlying 
“model” of sexual response that is uniform across women. A group of 111 nurses were asked 
which of three different models of sexual response–Masters and Johnson‟s (1966), Kaplan‟s 
(1974), and Basson‟s (2000)–best represented their own experience. Approximately equal 
proportions of women endorsed each of these three models and, interestingly, those women 
who endorsed the Basson model had lower scores on the Female Sexual Function Index 
(FSFI) (Rosen et al., 2000) (indicating worse sexual functioning) than women endorsing one 
of the other two models. 
 With regard to the endocrinology of sexual arousal, despite considerable research, our 
understanding of the relevance of hormones in women‟s sexual arousal is still limited. There 
is minimal evidence of a direct effect of estradiol on sexual arousability in women 
(Dennerstein, Burrows, Wood, & Hyman, 1980; Sherwin, 1991). Although there has been 
much interest in the role of testosterone in female sexuality, the evidence is inconsistent, 
compared to the male data, and there appears to be considerable variability in women‟s 
response to androgens (Graham, Bancroft, Greco, Tanner, & Doll, 2007). The role of 
peptides, such as oxytocin and prolactin, is also uncertain (Bancroft, 2005). 
Assessment of Genital Response 
Assessment of genital response in women is considered difficult in comparison with 
that of men (Bartlik & Goldberg, 2000). Levin (2003) pointed out that the relationship 
between vaginal lubrication and sexual arousal is uncertain. Although lubrication does 
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usually increase during sexual arousal, it may not be maintained, especially after a lengthy 
period of stimulation. It is also worth noting that although the essential criterion for a DSM 
diagnosis of FSAD is an inadequate “lubrication-swelling” response, the focus in almost all 
of the research has been on the lubrication aspect, and not on genital “swelling,” which 
presents considerable challenges in terms of measurement. Moreover, regarding lubrication 
difficulties, clinical and epidemiological research has relied almost exclusively on women‟s 
subjective reports of lubrication, i.e., not on any objective measurement of lubrication.  
Rather than measuring vaginal lubrication or swelling, studies dating back to the 
1970s investigating genital response in women have mainly assessed pulse amplitude in the 
vaginal wall (VPA), using vaginal photoplethysomography (Laan & Everaerd, 1995; 
Sintchak & Geer, 1975). There is now a large literature on VPA, although the methodology 
has a number of limitations (Levin, 2007). Increases in VPA occur quickly, often within a 
few seconds, in laboratory studies where women are presented with erotic stimuli (Laan & 
Everaerd, 1995), suggesting an “automatic” response (Laan & Both, 2008). A consistent 
observation has been that when subjective reports of arousal are correlated with VPA, the 
correlations are low in women (Chivers, Seto, Lalumière, Laan, & Grimbos, in press). In 
contrast, in men, the degree of penile erection correlates highly with subjective ratings of 
arousal and is usually always significant. In women, the most consistent pattern found in 
laboratory studies is that VPA occurs in response to sexual stimuli, but subjective sexual 
arousal is low or non-existent (Everaerd et al., 2000). As Everaerd et al. (2000) observed, 
“hardly ever was desynchrony between genital and subjective sexual arousal found to be the 
result of subjective sexual arousal without genital responding” (p. 122). 
There has been an implicit assumption in the literature that VPA is a measure of 
sexual arousal (Bancroft, 2009). However, there is uncertainty about the relationship of 
increased vaginal blood flow to sexual arousal in women (Levin, 2003). Although it is well 
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established that VPA increases when women are exposed to sexual stimuli, as noted above, 
this response appears to be fairly “automatic” (and may occur even when the stimuli are 
negatively evaluated by women) (Everaerd & Laan, 1995). 
More broadly speaking, it has been observed that, in comparison with men, genital 
arousal appears to be a less important factor in women‟s subjective sexual arousal (Everaerd 
& Laan, 1995). There have been various explanations put forth for the reasons for this gender 
difference, including social learning theories and biological explanations (e.g., anatomical 
differences between men and women) (Everaerd et al., 2000).  
It is possible that other aspects of genital response (e.g., clitoral blood flow) may be 
better indices of sexual arousal. There are other methods, such as labial thermistors, clitoral 
ultrasonography, and pelvic magnetic resonance imaging (for review, see Janssen, 2001) but 
to date none of these have gained widespread acceptance or been widely used. One major 
criticism has been the invasive methodology required for their placement on the genitals by 
the investigator. In two recent studies (Kukkonen, Binik, Amsel, & Carrier, 2007, 2009), 
genital temperature (assessed using thermal imaging) was significantly correlated with 
subjective ratings of sexual arousal in women. However, there are practical difficulties (e.g., 
cost, intrusiveness) with this measure. In addition, it has never been used to compare genital 
arousal responses between women with and without FSAD, so its diagnostic utility is 
unknown. 
In recent years, researchers have begun to utilize magnetic resonance imaging (MRI) 
to study the anatomy of the female genital and pelvic organs during sexual arousal (Maravilla 
& Yang, 2008; Suh, Yang, Heiman, Garland, & Maravilla, 2004). Although this research is at 
an early stage, findings suggest greater variability of response in women with FSAD, with 
some women showing virtually no response to sexual stimuli, and others showing responses 
that are indistinguishable from women without sexual difficulties (Maravilla & Yang, 2008).  
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Prevalence of FSAD  
 In an early review of the epidemiology of DSM-III psychosexual dysfunctions, the 
prevalence of “inhibited sexual excitement” was said to be “indeterminate” for women 
because so few studies had included questions about female genital response (Nathan, 1986). 
Since the publication of DSM-IV, there have been several large-scale epidemiological 
surveys that have reported prevalence rates for lubrication problems in women, many of 
which have used nationally representative and cross-cultural samples. A criticism of earlier 
studies that claimed to have used DSM criteria to establish sexual dysfunction was that they 
did not evaluate the presence of “marked distress or interpersonal difficulty” (Simons & 
Carey, 2001). More recent studies have assessed the presence of associated distress or 
impairment (Bancroft, Loftus, & Long, 2003; Oberg, Fugl-Meyer, & Fugl-Meyer, 2004; 
Shifren, Monz, Russo, Segreti, & Johannes, 2008; Witting et al., 2008).  
Notwithstanding these methodological improvements over earlier studies, some of the 
criteria required to make DSM diagnoses are difficult, if not impossible, to assess in large, 
population-based surveys (Graham & Bancroft, 2006). For example, while not part of the 
diagnostic criteria, the DSM text states that “a diagnosis of FSAD is…not appropriate if the 
problems in arousal are due to sexual stimulation that is not adequate in focus, intensity, and 
duration” (p. 501). One of the few studies that assessed complaints, such as “too little 
foreplay before intercourse,” was an early investigation by Frank, Anderson, and Rubinstein 
(1978). A total of 100 married couples completed a self-report questionnaire that assessed the 
presence or absence of sexual problems, such as “difficulty getting excited” and “difficulty 
maintaining excitement.” Almost half (48%) of the women reported difficulty becoming 
sexually aroused and 33% reported difficulty with maintaining arousal. However, 38% of 
these women also reported too little foreplay before sexual intercourse and 35% “disinterest.” 
Nathan (1986) suggested that, to obtain true estimates of the population rates of FSAD, 
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studies would need to assess the adequacy of sexual stimulation experienced by women. 
DSM-IV criteria also preclude a diagnosis of FSAD if the dysfunction was judged to be due 
exclusively to the physiological effects of a substance or a general medical condition, 
including “menopausal or postmenopausal reductions in estrogen levels” (p. 501). Because 
prevalence studies rarely obtain information on menopausal status, it is, therefore, important 
not to regard prevalence rates of lubrication problems as representing clinical diagnoses.  
Table 4 presents prevalence data reported by women from eight surveys. Most of 
these studies assessed problems with lubrication and not with “subjective” arousal or with 
other indices of genital arousal (e.g., swelling). Exceptions were the study by Dunn, Croft, 
and Hackett (1998), which asked about “problems being sexually aroused,” and the Bancroft 
et al. (2003) study, which included a composite variable (labelled “impaired physical 
response”) that comprised items on lack of subjective arousal, lack of pleasant genital 
tingling, and lack of enjoyment from genitals being touched. In a review of FSAD prevalence 
data in European countries since the mid-1980s, Fugl-Meyer and Fugl-Meyer (2006) found 
no studies that separated genital from “psychologic” arousal or that explicitly combined 
genital and subjective arousal. 
As Table 4 shows, the estimated prevalence rates for lubrication difficulties have 
varied widely. Although only assessed in a small number of studies, the duration of sexual 
problems and/or the recall period clearly affects prevalence rates (e.g., Mercer et al., 2003; 
Oberg et al., 2004). Mercer et al. compared prevalence rates for sexual problems reported as 
lasting at least one month in the past year (referred to here as “short-term”) with those lasting 
at least six months (“persistent problems”) in the last year. Although 9.2% of women reported 
short-term difficulties with lubrication, only 3.7% had persistent problems. Although Mercer 
et al. did not assess subjective feelings of arousal, the difference in prevalence estimates 
between short-term and persistent problems related to “lack of interest in sex” were striking 
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(40.6% vs. 10.2%, respectively). Hayes, Dennerstein, Bennett, and Fairley (2008) found that 
changing recall from “previous month” to “one month or more” increased prevalence rates 
for all female sexual dysfunctions. 
Almost all of the studies in Table 4 reported significant positive relationships between 
age and lubrication difficulties (e.g., Laumann, Paik, & Rosen, 1999; Najman, Dunne, Boyle, 
Cook, & Purdie, 2003; Richters, Grulich, de Visser, Smith, & Rissel, 2003). However, few 
epidemiological studies have recruited older, postmenopausal women. One recent exception 
was the Global Survey of Sexual Attitudes and Behaviors (Laumann et al., 2005), which used 
computer-assisted telephone interviewing and postal questionnaires in a sample of 9,000 
women aged 40-80 years from 29 countries. All of the women had had intercourse at least 
once in the previous year. The overall prevalence of lubrication difficulties (occasionally, 
periodically, frequently) varied from 16.1% (Southern Europe) to 37.9% (East Asia); the 
range for “frequent” problems was 4.7%-12.1%. Age showed a curvilinear relationship with 
the likelihood of lubrication difficulties in most, but not all, countries. Specifically, women 
aged 50-59 years were twice as likely as those aged 40-49 years to report lubrication 
problems; however, women in the oldest age group studied (70-80 years) were no more likely 
to have this complaint than the youngest age group (40-49 years). Although this study had 
several methodological problems (e.g., low response rate, differences in recruitment and 
method of assessment across sites), the findings underlined the importance of cultural factors 
in the experience of sexual problems.  
Comorbidity between FSAD and Other Sexual Dysfunctions 
In the DSM-IV text, under “Associated Features and Disorders,” the issue of 
comorbidity was noted: “Limited evidence suggests that Female Sexual Arousal Disorder is 
often accompanied by Sexual Desire Disorders and Female Orgasmic Disorder” (p. 501).  
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There is now robust evidence indicating a high degree of comorbidity between FSAD and 
other sexual disorders, particularly Hypoactive Sexual Desire Disorder (HSDD) (Basson et 
al., 2003; Fugl-Meyer & Fugl-Meyer, 2002; Laumann et al., 1999; Rosen, Taylor, Leiblum, 
& Bachmann, 1993; Segraves & Segraves, 1991a). In one study of patients with HSDD, 41% 
of the women had at least one other sexual dysfunction and 18% had diagnoses in all three 
categories i.e. desire, arousal, and orgasm (Segraves & Segraves, 1991a). A consistent 
observation in the literature has been that cases of FSAD seldom present on their own or even 
as the “primary problem” (Bancroft, Graham, & McCord, 2001; Basson, McInnes, Smith, 
Hodgson, & Koppiker, 2002; Heiman, 2002; Heiman & Meston, 1997; Meston & Bradford, 
2007; Rosen & Leiblum, 1995). In clinical settings, it has been pointed out that sexual 
problems in women most often affect all phases of the “sexual response cycle” (Basson & 
Weijmar Schultz, 2007). Heiman (2002) noted that there were no controlled treatment studies 
specifically related to FSAD. 
As discussed earlier, questions about whether FSAD should be considered as a 
disorder distinct from desire and orgasm were raised in the literature before DSM-IV was 
introduced (Segraves, 1996a). In a clinical series of 532 women with sexual complaints, 40 
(7.5%) met DSM-III-R criteria for having an arousal disorder; however, the majority of these 
women also met criteria for desire or orgasm disorders. Indeed only eight women (1.5%) had 
a single diagnosis of arousal disorder (Segraves & Segraves, 1991b). It was concluded that 
“The infrequency with which female arousal disorder is a solitary diagnosis raises the 
question of whether this should be retained as a diagnostic entity” (p. 9). As discussed above, 
the main reason that FSAD was retained in DSM-IV was a desire to maintain consistency 
between male and female diagnostic categories, and between the DSM and ICD-10 
classification systems. 
The Relationship between Sexual Arousal and Sexual Desire  
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As stated earlier, sexual desire, as an expression of incentive motivation, can be seen 
as the first component of sexual arousal and may be experienced together with varying 
degrees of the other components (e.g., general arousal, genital response) (Bancroft, 2005). 
Hence, it is not surprising that in addition to significant comorbidity between desire and 
arousal disorders, there is also increasing support for the idea that arousal and desire are not 
distinct phases of sexual response and are not experienced as such by women themselves. 
Evidence comes from a number of sources. 
Qualitative research supports the idea that women often do not differentiate between 
sexual “desire” or “interest” and “arousal” (Beck, Bozman, & Qualtrough, 1991; Brotto, 
Heiman, & Tolman, 2009; Ellison, 2000; Graham, Sanders, Milhausen, & McBride, 2004). 
Further, contrary to the assumptions underlying the HSRC model (Tiefer, 1991), there does 
not appear to be any universal temporal sequence (e.g., from desire to arousal). Women 
sometimes report sexual interest preceding sexual arousal, and at other times following it 
(Graham et al., 2004). Other studies have reported significant correlations between sexual 
desire and arousal (Beck et al., 1991; Sanders, Graham, & Milhausen, 2008), and it has been 
suggested that sexual desire and arousal may be “two facets of the same process within the 
sexual response” (Beck et al., 1991, p. 454). This suggestion is consistent with the incentive 
motivation model. Laan and Both (2008) summarized evidence that the experience of sexual 
“desire” may follow from rather than precede sexual arousal and concluded that “...there is no 
good reason to assume that feelings of desire and arousal are two fundamentally different 
things” (p. 510). Laan and Both suggested that arousal and desire might be distinguished on a 
phenomenological level in that feelings of arousal might reflect the subjective experience of 
genital changes, and feelings of desire the “subjective experience of an action tendency, of a 
willingness to behave sexually” (p. 510).  
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 In contrast with men, studies involving clinical samples of women have also 
demonstrated a significant overlap between the dimensions of desire and arousal. For 
example, in their evaluation of the FSFI, Rosen et al. (2000) compared a group of women 
diagnosed with FSAD with a group of women without sexual complaints. In a principal 
components analysis of the questionnaire items, the first component included measures of 
both sexual desire and arousal (particularly in the FSAD group). It was observed that this 
finding “demonstrates a considerable overlap between the dimensions of desire and arousal in 
women, consistent with clinical observation and contrasting with findings in studies of sexual 
dysfunction in men” (p. 202). However, although acknowledging the overlap between desire 
and arousal, Rosen et al. stated “…a clinically based decision was made to separate the mixed 
factor of desire/arousal into two measurable dimensions” (p. 202). 
In a study that sought to build a model of mid-aged women‟s sexual arousal, 
Dennerstein, Lehert, and Burger (2005) found that items on women‟s sexual responsiveness 
or arousal were not separable from items relating to sexual desire. Measures of sexual 
functioning developed for use with men (e.g., the Brief Index of Sexual Functioning (BISF)) 
(Taylor, Rosen, & Leiblum, 1994) have been found to have very different factor structures 
when they are modified for use with women. Heiman (2001) noted that the female desire 
factor was “strikingly different” on the female BISF questionnaire from the desire factors on 
the male questionnaire. Heiman concluded that “the results from these measures …strongly 
suggest that women‟s sexuality may be organized differently from that of men” (p. 120). 
 In sum, although there is now good evidence that desire and arousal in women are not 
easy to differentiate, they continue to be defined, and studied, as independent constructs 
(Graham et al., 2004). The primary reason for this appears to be the need to maintain the 
continuity of the current DSM-IV classification of separate desire and arousal disorders 
  
 
 
 
18 
(Basson et al., 2000; Rosen et al., 2000), as well as the strong historical influence of Masters 
and Johnson (1966), Kaplan (1974), and their associated models.  
Association between Lubrication Problems and Distress 
 A number of recent studies have assessed personal distress (Criterion B) associated 
with sexual arousal difficulties (e.g., Bancroft et al., 2003; Hayes et al., 2008; King, Holt, & 
Nazareth, 2007; Oberg et al., 2004; Shifren et al., 2008; Witting et al., 2008). A consistent 
finding across these studies has been that sexual problems, even if moderate/severe, do not 
always cause distress. Although lubrication problems appear to be more frequently associated 
with distress than other sexual problems (Oberg et al., 2004; Witting et al., 2008), in one 
study, 11% of women classified as having “manifest” lubrication problems (defined as 
experience of difficulties “quite often,” “nearly all the time,” or “all of the time”) did not 
report any distress about their symptoms (Oberg et al., 2004). In a study involving 31,581 
U.S. women recruited through a national research panel (Shifren et al., 2008), distress was 
assessed with the Female Sexual Distress Scale (Derogatis, Rosen, Leiblum, Burnett, & 
Heiman, 2002). Women were classified as having “low arousal” if they responded “never” or 
“rarely” to three questions: “How often do you become sexually aroused?”, “Are you easily 
aroused?”, and “Do you have adequate lubrication?” While the age-adjusted prevalence of 
current “low arousal” was 25.3%, the prevalence of arousal problems with associated distress 
was considerably lower (3.3%-6.0%, depending on age). Physical health problems and 
current depression were associated with increased odds of arousal problems, as was 
menopausal status.  
Bancroft et al. (2003) assessed the prevalence of women‟s distress about their sexual 
relationship, as well as distress about “their own sexuality” in the previous month. Among the 
women who complained of lubrication difficulties (31.2% of their sample), 7.3% reported 
“marked distress” about their relationship and 6.5% about their own sexuality. In the overall 
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sample, the best predictors of distress were indicators of emotional and relationship well-
being and the quality of the emotional relationship with the partner. “Impaired arousal” (a 
composite variable including genital symptoms but also subjective response) was a relatively 
weak predictor of distress about the sexual relationship. It is noteworthy that lubrication and 
other physical aspects of arousal, such as orgasm, were not significant predictors of distress, 
leading Bancroft et al. to conclude, “In general, the predictors of distress about sex did not fit 
well with the DSM-IV criteria for the diagnosis of sexual dysfunction in women” (p. 193). 
King et al. (2007) compared ICD-10 clinical diagnoses of sexual dysfunction with 
women‟s own perceptions of whether or not they had a sexual problem and found a 
significant discordance between the two. Overall, although 38% of women were deemed to 
have an ICD-10 diagnosis of a sexual dysfunction, only 18% of women received a diagnosis 
and also perceived that they had a problem (and only 6% considered their problem 
“moderate” to “severe”). Four percent of women reported lubrication symptoms, but only 2% 
perceived these as a problem, and even less (0.5%) regarded the problem as “somewhat” or 
“very” distressing. The lower prevalence of lubrication problems in this study may have been 
due to the relatively young age of the sample (M = 37.8 years). 
Studies that have investigated the relationship between the experience of sexual 
problems and “satisfaction” with sexual relations have similarly found that women with 
sexual difficulties do not necessarily report dissatisfaction. In the study discussed earlier by 
Frank et al. (1978), while close to half (48%) of the married women in their sample reported 
“difficulty getting excited,” 86% nonetheless described their sexual relationship as 
“moderately satisfying” or “very satisfying.” Interestingly, however, “difficulty getting 
excited” was the sexual problem most strongly correlated with sexual dissatisfaction (r = 
0.41); in comparison, difficulty in reaching orgasm (r = 0.22) and inability to have an orgasm 
(0.18) were less correlated with sexual dissatisfaction. In a recent community-based study of 
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U.S. women aged 30-79 years, a 38.4% prevalence rate of “sexual problems” was obtained, 
but only 13.7% of the participants reported both sexual problems and dissatisfaction with 
their sex lives (Lutfey, Link, Rosen, Wiegel, & McKinlay, 2009).  
Factors underlying FSAD 
 Many possible causes of FSAD have been proposed, from physiologic factors (e.g., 
hormonal, medication, vascular disease) to psychological factors (e.g., anxiety, depression, 
distraction) (for reviews, see Meston & Bradford, 2007; Nappi, Ferdeghini, & Polatti, 2006; 
West, Vinikoor, & Zolhoun, 2004). Prior to the introduction of sildenafil to treat male erectile 
problems, there was little investigation of possible physiological factors underlying sexual 
arousal problems in women. In the last decade, there has been a focus on possible 
physiological causes of FSAD (e.g., Berman & Bassuk, 2002; Nappi et al., 2006); despite 
this, any underlying pathophysiology of sexual arousal problems, if it exists, is not well 
understood (Bancroft, 2009).  
Relationship difficulties and partner variables have consistently predicted reports of 
sexual problems (Dennerstein et al., 2005; Witting et al., 2008) as well as associated distress 
(Bancroft et al., 2003; Rosen et al., 2009). 
Although reduced vaginal lubrication is often attributed to low estrogen levels in 
postmenopausal women, there is some evidence that vaginal atrophy but not vaginal dryness 
is associated with decreased estrogen (Laan & van Lunsen, 1997). Based on findings from a 
longitudinal dataset involving 438 Australian women who were followed through their 
menopausal transition, Dennerstein et al. (2005) concluded that prior sexual functioning and 
relationship variables were more predictive of women‟s sexual functioning than hormonal 
factors. Findings from psychophysiological studies of sexual arousal also suggest that arousal 
problems in healthy premenopausal women are more often associated with inadequate sexual 
stimulation than with physical causes (van Lunsen & Laan, 2004). 
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 Regarding psychological factors, there has been less research on variables specifically 
associated with FSAD. Negative cognitions and attitudes about sexuality may make women 
more vulnerable to experiencing arousal difficulties (Middleton, Kuffel, & Heiman, 2008; 
Nobre & Pinto-Gouviea, 2006, 2008). Cognitive distraction from erotic cues, sometimes 
induced by self-consciousness about body image (Dove & Wiederman, 2000), can also 
reduce sexual arousal. There is evidence that a history of sexual abuse is more common 
among women with arousal difficulties (Laumann et al., 1999).  
PREVIOUS CRITIQUES OF DSM CRITERIA AND ALTERNATIVE 
CLASSIFICATION SYSTEMS 
 
 The DSM-IV classification system for female sexual dysfunction has received 
considerable criticism (Bancroft et al., 2001; Boyle, 1994; Tiefer, 1996, 2001). Some authors 
have suggested revised definitions and diagnostic criteria, while preserving the underlying 
structure of the DSM system, i.e., desire, arousal, orgasm, and pain disorders (Basson et al., 
2000, 2003). Others have called for alternative classification systems (Hartmann et al., 2002; 
Tiefer, 2001).  
 The Report of the International Consensus Development Conference on Female 
Sexual Dysfunction (Basson et al., 2000) was written following a conference funded by the 
American Foundation for Urologic Disease in which 19 experts reviewed the DSM-IV 
criteria. Regarding FSAD, the definition was expanded to include nongenital and subjective 
dimensions of arousal. Sexual arousal disorder was defined as “the persistent or recurrent 
inability to attain or maintain sufficient mental excitement, causing personal distress, which 
may be expressed as a lack of subjective excitement, or genital (lubrication/swelling) or other 
somatic responses” (p. 890). The rationale behind the recommendation to change the DSM 
requirement from “marked distress and interpersonal difficulty” to “personal distress” was 
not clear.  
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 In 2002 and 2003, an international multidisciplinary group was convened to further 
review the definitions of women‟s sexual dysfunctions and recommendations were made for 
expansion and revision of diagnostic categories (Basson et al., 2003, 2004). Regarding 
FSAD, criticism was directed at the DSM-IV focus on women‟s genital response and the 
omission of both subjective and non-genital physiological changes from the diagnostic 
criteria. The committee proposed the following three subtypes of FSAD: (1) Subjective 
sexual arousal disorder; (2) Genital sexual arousal disorder; and (3) Combined genital and 
subjective arousal disorder. The third subtype was viewed as being the “most common 
clinical presentation” and was “usually comorbid with lack of sexual interest” (p. 226). An 
important addition to the definition of genital arousal disorder was that it included “marked 
loss of intensity of any genital response including orgasm” (i.e., the focus was not just on 
lubrication). Other recommendations were to clarify the degree of distress (as none, mild, 
moderate, or marked) and to include the following “contextual descriptors” of the diagnosis: 
(1) past factors (e.g., negative upbringing, past trauma); (2) interpersonal difficulties (e.g., 
partner sexual dysfunction); and (3) medical and psychiatric conditions, medications, or 
substance abuse. 
 The above recommendations for revision of diagnostic criteria preserve the main 
DSM-IV categories of desire, arousal, and orgasm disorders. In contrast, the New View of 
Women‟s Sexual Problems (The Working Group for a New View of Women‟s Sexual 
Problems, 2001), written by a group of clinicians and social scientists, offered a new 
classification system and a “woman-centered” definition of sexual problems as: “discontent 
or dissatisfaction with any emotional, physical, or relational aspect of sexual experience” (p. 
5). Criticisms of DSM-IV were that it ignored gender differences in sexuality, relational 
aspects of women‟s sexuality, and individual differences in sexual experience among women. 
The New View classification system is not based on symptom criteria but organized around 
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four possible categories of causes: sociocultural, political, or economic factors; partner and 
relationship factors; psychological factors; and medical factors. A study of 49 British women 
(Nicholls, 2008) evaluated the utility of this system. Women‟s descriptive accounts of their 
sexual problems were analysed qualitatively and issues identified in their narratives 
compared with the New View categories. The findings suggested a “good fit”; the majority of 
issues raised by women could be classified using the New View scheme. The majority (65%) 
of women‟s sexual difficulties were classified as partner- or relationship-related problems. 
Although this was a small study, it is the only study to date that has evaluated the 
classification system, and the findings do provide some support for the clinical utility of the 
New View scheme. 
Hartmann et al. (2002) also argued that a new classification system for women‟s 
sexual dysfunction was needed and that “…by simply expanding and continuing DSM-IV 
criteria and the traditional response cycle classification systems, it is impossible to come to 
diagnostic categories and subtypes that adequately reflect real-life female sexual problems” 
(p. 85). Hartmann et al.‟s major criticism of the DSM classification system, and also of the 
revised Basson et al. (2000) definitions, was that female sexual problems do not relate to a 
single phase of a hypothetical response cycle, but instead reflect “a more or less global lack 
of sexual interest, arousability, and arousal” (p. 85). Hartmann et al. also recommended that a 
new classification system take etiological and comorbidity factors into account. In two 
empirical studies of women with low sexual desire, they found significant comorbidity and 
high rates of psychological distress in their samples. Although Hartmann et al. made some 
suggestions for classifying hypoactive sexual desire disorders, including arousal complaints 
as a specifier for some desire disorders, they did not propose a new classification system, 
emphasizing instead the need for a better understanding of the mechanisms underlying sexual 
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disorders and, in particular, more qualitative research of women‟s experiences of sexual 
problems. 
CRITIQUE OF SPECIFIC DSM CRITERIA FOR FSAD 
 Specific aspects of the DSM-IV-TR criteria for FSAD will now be considered and 
recommendations made for revision.  
Criterion A 
 The essential feature of the diagnosis of FSAD is that there is insufficient vaginal 
lubrication/swelling (“Persistent or recurrent inability to attain or to maintain until 
completion of the sexual activity, an adequate lubrication-swelling response of sexual 
excitement”).  
The requirement that symptoms be “persistent and recurrent” has been criticized as 
overly vague and likely to lead to undue reliance on clinician judgment, with negative 
consequences for both clinical and epidemiological research (Segraves, Balon, & Clayton, 
2007). As reviewed above, prevalence studies on FSAD have reported rates for short-term 
problems that are significantly higher compared to persistent problems (Mercer et al., 2003). 
Although we have little empirical data comparing reports of sexual problems across different 
time periods, some authors have recommended more specific duration and severity criteria 
(Balon, 2008; Balon, Segraves, & Clayton, 2007; Segraves et al., 2007). Specific 
recommendations for all of the sexual dysfunctions have been that symptoms should be 
present for six months or more and occur in 75% or more of sexual encounters. 
The basis for choosing lubrication/swelling as the sole criterion, and the omission of 
subjective excitement/pleasure from the DSM-IV criteria set, was likely related to the 
erroneous assumption that vaginal lubrication was the female equivalent of male penile 
erection. As discussed above, there is evidence that increases in vaginal blood flow in women 
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may be a relatively “automatic response” (Laan & Everaerd, 1995) and one that women may 
or may not be aware of (Bancroft, 2009).  
Although many authors attribute this emphasis on genital response to Masters and 
Johnson (1966), their research demonstrated that many “extragenital” physiological changes 
occurred during sexual arousal (e.g., myotonia, nipple erection). In their book on female 
sexual behavior, Kinsey, Pomeroy, Martin, and Gebhard (1953) also commented that “sexual 
responses obviously involve a great deal more than genital structures” and that “every part of 
the mammalian body may be involved whenever there is sexual response, and many parts of 
the body may respond as notably as the genitalia during sexual contact” (p. 623). Recent 
qualitative studies have likewise found that women report a wide range of physical (genital 
and nongenital), cognitive/emotional, and behavioral changes with sexual arousal, with 
genital changes only one dimension, and not necessarily the most salient one (Brotto et al., 
2009; Graham et al., 2004). In a focus-group study of women aged 18-84 years (Graham et 
al., 2004), participants described occasions where they experienced vaginal lubrication but 
were not sexually aroused and other situations where they felt sexually aroused but were not 
lubricated. Given that sexual arousal clearly involves many physiological and psychological 
changes, defining problems with sexual arousal only with reference to impaired genital 
response appears problematic. 
Another major problem with the lubrication/swelling criterion is that there is little 
evidence that women with arousal disorder have impaired genital response. In an early study, 
Morokoff and Heiman (1980) found no significant differences in VPA between women 
diagnosed with sexual arousal disorder and a control group of women. In a study of 
premenopausal women with sexual arousal problems, following suggested definitions of 
Basson et al. (2003), women were classified into three subtypes: genital, subjective, and 
combined (subjective and genital) sexual arousal disorder (Brotto, Basson, & Gorzalka, 
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2004). Only those women in the “genital” subgroup, characterized by self-reports of impaired 
genital sensitivity, showed evidence of impaired genital response. The VPA response of 
women with subjective or combined symptoms (believed to constitute the majority of those 
who seek treatment) did not differ from those of a control group of women. Recently, Laan, 
van Driel, and van Lunsen (2008) evaluated whether women diagnosed with FSAD using 
DSM-IV criteria showed less genital response to visual sexual stimuli than a control group of 
women without sexual problems. They found no significant differences between the groups 
in VPA; however, women with FSAD reported less positive and slightly more negative affect 
in response to the erotic films. Laan et al. concluded: “The sexual problems these women 
report are clearly not related to their potential to become genitally aroused…In medically 
healthy women, impaired genital responsiveness is not a valid diagnostic criterion” (p. 1424). 
There is some evidence that VPA may be impaired in women who have chronic physical 
illness or following pelvic surgery. For example, studies have reported that women with 
diabetes (Wincze, Albert, & Bansal, 1993) and women who had undergone radical 
hysterectomy for cervical cancer (but not those having had simple hysterectomies) (Maas et 
al., 2004) had lower VPA in response to erotic films than control groups of women. 
In support of the argument that women‟s awareness of genital response should not be 
the central feature of the diagnosis of FSAD is the fact that phosphodiesterase type 5 inhibitor 
drugs (PDE-5i), such as sildenafil (Viagra®), met with little success in controlled treatment 
trials involving women with FSAD (Basson et al., 2002; Laan, van Lunsen, & Everaerd, 
2001). Although these drugs increased genital vasocongestion, this was not associated with 
any perceived increase in subjective arousal by women (Basson et al., 2002).  
There is some evidence that the use of personal lubricants has increased in recent 
years, both for enhancement of sexual pleasure but also to treat problems with vaginal 
dryness (Herbenick, Reece, Hollub, Satinsky, & Dodge, 2008; Herbenick et al., in press). The 
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issue of lubrication difficulties may, therefore, be less relevant today, given the wide 
availability of these products, at least in Western societies. It should also be noted that 
lubrication as a positive sign of sexual arousal is culture-specific, as some societies, both in 
Africa and in the Caribbean, value “dry sex,” i.e., the use of plants to dry and contract the 
vagina, for the purpose of increasing sensation for the man during intercourse (van Andel, de 
Korte, Koopmans, Behari-Ramdas, & Ruysschaert, 2008). 
In summary, there is strong evidence that the criterion of vaginal lubrication alone is 
insufficient to diagnose sexual arousal problems in women. The recommendations made 
below reflect the belief that a woman‟s subjective awareness of arousal should be a central 
component of the symptom criteria and that additional genital and non-genital aspects of 
physiological response, i.e., not simply lubrication/swelling, also be included. It seems 
crucial that diagnostic criteria adopted reflect the considerable heterogeneity of women‟s 
experiences of sexual arousal and individual differences across women. 
Criterion B 
Criterion B requires that “the disturbance causes marked distress or interpersonal 
difficulty.” There has been considerable discussion in the literature regarding the distress 
criterion (Althof, 2001; Bancroft et al., 2003; Hayes, 2008; Mitchell & Graham, 2008). Some 
have argued that personal or interpersonal distress should not be included in the symptom 
criteria for the diagnosis of sexual dysfunction (Althof, 2001; Segraves et al., 2007). The 
issue of distress is acknowledged to be a difficult one (Mitchell & Graham, 2008); on the one 
hand, logically it seems that lack of distress should not preclude a diagnosis from being made 
(and, as discussed above, we know that some women meet diagnostic criteria for a sexual 
disorder but report no distress about it [King et al., 2007]). On the other hand, without 
assessing distress, prevalence rates for sexual problems are markedly higher. Some 
epidemiological studies, which have not assessed distress, have been criticized for producing 
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estimates of “sexual dysfunction” that are widely agreed to be inflated. The best example of 
this was the publication in the Journal of the American Medical Association of a study on the 
epidemiology of “sexual dysfunction” (Laumann et al., 1999). In this widely cited paper, 
43% of women and 31% of men were identified as having a “sexual dysfunction,” described 
as “a largely uninvestigated yet significant public health problem” (p. 544). A 43% 
prevalence rate of any dysfunction seriously calls into question whether this is indeed 
pathology or the norm. Distress was not assessed in this study and duration was 
operationalized as “several months or more” during the past year. As discussed earlier, 
studies have consistently reported lower prevalence rates for sexual dysfunction when 
distress is required (Hayes et al., 2008; Oberg et al., 2004; Witting et al., 2008) and the recall 
period used also affects prevalence estimates (Hayes et al., 2008). 
 In practice, an individual and/or their partner who is not distressed by a sexual 
concern is unlikely to seek treatment (Bancroft et al., 2001). Also, Segraves et al. (2007) 
pointed out that the inclusion of the distress criterion in DSM-IV could be considered an 
unnecessary addition, given that the introductory text makes explicit that a behavioral pattern 
can be considered a psychiatric disorder only if it engenders distress or disability. However, 
assessing distress in a clinical situation, including the distinction between so-called 
“personal” distress and “interpersonal” distress, is clearly important and can inform treatment 
decisions.  
 A distinction might usefully be made between ascertaining a sexual problem is 
present (based on self-report and behavior) and diagnosing a “sexual dysfunction” on the 
basis of distress and/or impairment in addition to the relevant symptoms. The 
recommendation made here is that the requirement that distress or interpersonal difficulty be 
present be retained as Criterion B; rather than a categorical assessment of whether distress is 
present or absent, the degree of distress that women (and their partners) are experiencing in 
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relation to a sexual problem would be assessed on a dimensional scale (Regier, 2008; 
Widiger & Samuel, 2005). 
Criterion C 
 Criterion C requires that “the sexual dysfunction is not better accounted for by 
another Axis I disorder (except another Sexual Dysfunction) and is not due exclusively to the 
direct physiological effects of a substance (e.g., a drug of abuse, a medication) or a general 
medical condition.” This criterion seems both unrealistic (in that it is questionable whether it 
can ever be established that a sexual problem is due exclusively to one or another cause) and 
inconsistent with more recent approaches to therapy, which emphasize the need for an 
integrated approach (Graham & Bancroft, 2009). One example of this related to male ED is 
that the earlier focus on physical causes and treatment using PDE-5i has shifted to a greater 
recognition of the importance of partner variables and relationships in clinical management of 
cases (Fisher, Rosen, Eardley, Sand, & Goldstein, 2005; Heiman et al., 2007).  
In view of the above, I suggest that Criterion C either be revised to acknowledge the 
fact that, in the majority of cases, the causes of arousal disorders are (1) multifactorial or (2) 
cannot be specified, or be deleted altogether. 
DSM-IV-TR Diagnostic Subtypes 
 As mentioned earlier, DSM-IV provides subtypes to “indicate the onset, context, and 
etiological factors associated with the Sexual Dysfunctions” (p. 494).  
 The first two of these subtypes, “lifelong” vs. “acquired” and “generalized” vs. 
“situational,” seem potentially useful for clinical purposes, although it is worth noting that, in 
epidemiological research, these distinctions have very rarely been made. The 
recommendation made here would be to retain these distinctions, although rather than include 
these as “subtypes” they could instead be incorporated as specifiers (discussed further 
below).  
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 The final subtypes, “Due to Psychological Factors” and “Due to Combined Factors,” 
seem to be less relevant for either clinical or research purposes. As discussed above in 
relation to Criterion C, in practice it is often impossible to ascertain the causes of sexual 
arousal problems and, in most cases, both psychological and physical factors are implicated 
(Basson & Weijmar Schultz, 2007). 
PROPOSED REVISION TO DSM-IV CATEGORY OF FSAD 
 This review has highlighted the longstanding dissatisfaction that both researchers and 
clinicians have expressed about the DSM-IV diagnostic criteria for female sexual 
dysfunction. Over a decade ago, Rosen and Leiblum (1995) commented that “…the 
diagnostic nosology continues to be based on Kaplan‟s model…despite a relative paucity of 
empirical support for this model” (p. 879). There have been several revised definitions and 
modifications to diagnostic criteria put forward over the last decade but, with one notable 
exception (The Working Group for a New View of Women‟s Sexual Problems, 2001), all of 
these have retained the basic DSM categories of desire, arousal, and orgasm disorders. 
Despite the recognition that using the HSRC as the framework for classifying women‟s 
sexual disorders is unsatisfactory, there has been a reluctance to relinquish the diagnostic 
categories of desire, arousal, and orgasm disorders and “return to the drawing board” 
(Mitchell & Graham, 2008). In an article on dilemmas in the pathway of the DSM-IV, Carson 
(1991) discussed the dangers of “…tinkering on a superficial level with operational criteria 
that tend over time to approach the status of revealed truths, notwithstanding their often 
patently arbitrary nature and the unproductiveness of their outcomes” (p. 304). This concern 
seems pertinent in the context of classification of women‟s sexual problems; indeed, it 
appears that the categories of “desire” and “arousal” disorders have been reified to some 
extent. 
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 In recognition of the empirical research suggesting a lack of differentiation between 
sexual desire and arousal in women and the high degree of comorbidity between FSAD and 
HSDD, the proposal here is to merge these two diagnostic categories. The suggested name for 
the disorder is Sexual Interest/Arousal Disorder. 
 It is recommended that a polythetic approach to the diagnosis of this disorder be used, 
consistent with many other categories of dysfunction in the DSM. The advantage of this 
approach is that it recognizes the heterogeneity inherent in women‟s sexual experiences, and 
does not prioritize any one “type” of arousal (e.g., genital, subjective, etc.). A preliminary list 
of proposed criteria is presented in Table 5. The precise number of symptoms required in 
order to meet criteria for “Sexual Arousal/Interest Disorder” needs further consideration, and 
field trials should be conducted to evaluate what number and level of symptoms should be 
required for a diagnosis. 
 Although there has been little empirical data to inform the choice of specific, severity, 
and frequency criteria, in view of the evidence that mild and transient sexual problems are 
very common, and to avoid pathologizing normal variation in sexual experiences (Segraves et 
al., 2007), it seems important to specify some level of symptoms that are required for a 
diagnosis. Field trials should be set up to evaluate the validity of using different severity/ 
duration criteria. 
Specifiers  
A major recommendation in the present review is an expanded use of the category of 
specifiers. Specifiers are typically used to “describe the course of the disorder or to highlight 
prominent symptoms” or to “indicate associated behavioral patterns of clinical interest” 
(Beach, Wamboldt, Kaslow, Heyman, & Reiss, 2006, p. 364). Basson et al. (2003) advocated 
the use of “contextual descriptors”; based on previous research, they suggested the following 
three categories of descriptors: (1) negative upbringing/losses/trauma, past interpersonal 
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relationships, cultural/religious restrictions; (2) current interpersonal difficulties, partner 
sexual dysfunction, inadequate stimulation and unsatisfactory sexual and emotional contexts; 
(3) medical conditions, psychiatric conditions, medications, or substance abuse. These 
descriptors are similar to the “three windows approach” put forward by Bancroft (2009). 
Bancroft suggested that, in a clinical assessment, the following three “windows” be used to 
consider factors that might alter or impair an individual‟s capacity for sexual response: (1) the 
current situation (including factors such as expectations about sex, negative mood, concerns 
about pregnancy or sexually transmitted infection); (2) vulnerability to sexual problems 
(including negative cognitions, earlier trauma or abuse, propensity for sexual inhibition); (3) 
factors that alter sexual function (including the impact of aging, physical illness, 
medications). 
The recommendation is that, in addition to the subtypes Lifelong or Acquired, 
Generalized or Situational, the proposed specifiers for Sexual Interest/Arousal Disorder (see 
Table 5) are: partner factors (e.g., partner‟s sexual problems, partner‟s health status); 
relationship factors (e.g., poor communication, relationship discord, discrepancies in desire 
for sexual activity); individual vulnerability factors (e.g., depression or anxiety, poor body 
image, history of abuse experiences); and cultural/religious factors (e.g., inhibitions related to 
prohibitions about sexual activity). These specifiers are proposed based on previous research 
that suggest these variables are ones that may be relevant to etiology and/or to choice of 
treatment. 
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Table 1.  
DSM-III Diagnostic Criteria for Inhibited Sexual Excitement (302.72) 
A. Recurrent and persistent inhibition of sexual excitement during sexual activity, 
manifested by: 
In Males, partial or complete failure to attain or maintain erection until 
completion of the sexual act, or 
In Females, partial or complete failure to attain or maintain the lubrication-
swelling response of sexual excitement until completion of the sexual act. 
B. A clinical judgment that the individual engages in sexual activity that is adequate in 
focus, intensity, and duration. 
C. The disturbance is not caused exclusively by organic factors (e.g., physical disorder 
or medication) and is not due to another Axis 1 disorder. 
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Table 2.  
DSM-III-R Diagnostic Criteria for Female Sexual Arousal Disorder (302.72) 
A. Either (1) or (2): 
(1) persistent or recurrent partial or complete failure to attain or maintain the 
lubrication-swelling response of sexual excitement until completion of the sexual 
activity 
(2) persistent or recurrent lack of a subjective sense of sexual excitement and pleasure 
in a female during sexual activity 
B. Occurrence not exclusively during the course of another Axis I disorder (other than a 
Sexual Dysfunction), such as Major Depression. 
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Table 3.  
DSM-IV Diagnostic Criteria for Female Sexual Arousal Disorder (302.72) 
A. Persistent or recurrent inability to attain, or to maintain until completion of the sexual 
activity, an adequate lubrication-swelling response of sexual excitement.  
B. The disturbance causes marked distress or interpersonal difficulty. 
C. The sexual dysfunction is not better accounted for by another Axis I disorder (except 
another Sexual Dysfunction) and is not due exclusively to the direct physiological effects 
of a substance (e.g., a drug of abuse, a medication) or a general medical condition. 
Specify type: 
 Lifelong Type 
 Acquired Type 
Specify type: 
 Generalized Type 
 Situational Type 
Specify: 
 Due to Psychological Factors 
 Due to Combined Factors 
Table 4.  
Prevalence of Arousal Problems in Selected Epidemiological Studies.  
 
Study 
 
N of women 
 
Country 
 
Age 
 
Method of assessment 
 
Time period 
 
Prevalence 
 
 
Bancroft et 
al., 2003 
 
 
 
 
Dunn et al.,  
1998 
 
 
987; 
all in 
heterosexual 
relationships 
 
 
979 
 
 
United 
States 
 
 
 
 
UK 
 
20-65 
 
 
 
 
 
18-75 
 
Computer-assisted 
telephone interviewing 
 
 
 
 
Postal questionnaire 
 
Previous 
month 
 
 
 
 
Last 3 mos. 
 
“Lubrication problems”: 31.2% 
“Impaired arousal”: 12.2% 
 
 
 
 
Vaginal dryness: 28% 
Arousal problems: 17.0% 
 
 
Laumann et 
al., 1999 
 
1,749; all 
sexually active 
over last 12 mos. 
 
 
United 
States 
 
18-59 
 
Face-to-face interview 
 
Several mos. 
or more 
during past 
12 mos. 
 
 
“Trouble lubricating”: 20.6% 
 
 
 
 
 
Mercer et al., 
2003 
 
4,826; all had at 
least 1 
heterosexual 
partner in last 12 
mos. 
 
 
UK 
 
16-44 
 
Computer-assisted self-
interview 
 
Past 12 mos. 
 
Trouble lubricating: 
 Lasted at least 1 mo.: 9.2% 
 Lasted at least 6 mos.: 2.6% 
 
 
Najman et al., 
2003 
 
 
 
908 
 
 
 
 
Australia 
 
 
 
 
18-59 
 
 
 
 
Telephone interview 
 
 
 
 
Several mos. 
or more 
during past 
12 mos. 
 
21-30% 
(depending  
on age) 
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Oberg et al., 
2004 
1,056, all 
sexually active 
during last 12 
mos. 
 
Sweden 18-65 Structured face-to-face 
interview + 
questionnaires 
Past 12 mos. 
 
 
Past 12 mos. 
Insufficient lubrication: 
Manifest
*
: 12%; Mild: 50% 
Richters et al., 
2003 
9,134  Australia  16-59 Computer-assisted 
telephone interview 
At least 1 
month in the 
past 12 mos. 
Trouble with vaginal dryness: 23.9% 
 
Witting et al., 
2008 
 
5,463 women  
 
Finland 
 
18-49 
 
Questionnaires (FSFI + 
FSDS) 
 
Past month 
 
Lubrication difficulties (met FSFI cut-
off of 4.31): 10.9% 
Met FSFI cut-off and reported 
distress: 7.0% 
 
*Note: manifest = “quite often”, “nearly all the time”, and “all the time”; mild = “hardly ever” and “quite rarely”. ** FSFI = Female 
Sexual Function Index (Rosen et al., 2000); FSDS = Female Sexual Distress Scale (Derogatis et al., 2002).
Table 5.  
Proposed criteria for Sexual Interest/Arousal Disorder 
A. Lack of sexual interest/arousal, of at least 6 months duration, as manifested by at least three of 
the following indicators:  
1.  Absent/reduced interest in sexual activity  
2. Absent/reduced sexual/erotic thoughts or fantasies  
3. No initiation of sexual activity and is not receptive to a partner‟s attempts to initiate  
4. Absent/reduced sexual excitement/pleasure during sexual activity (on at least 75% 
or more of sexual encounters)  
5. Absent/reduced genital and/or non-genital physical changes during sexual activity 
(on at least 75% or more of sexual encounters)  
B. The disturbance causes clinically significant distress or impairment  
Specifiers:  
1) Lifelong or acquired 
2) Generalized or situational 
3) Partner factors (partner‟s sexual problems, partner‟s health status) 
4) Relationship factors (e.g., poor communication, relationship discord, discrepancies in 
desire for sexual activity)  
5) Individual vulnerability factors (e.g., depression or anxiety, poor body image, history of 
abuse experiences) 
6) Cultural/religious factors (e.g., inhibitions related to prohibitions against sexual activity) 
7) Medical factors (e.g., illness/medication) 
